AM EST. Biocartis Showcases Growing Impact of Idylla™ Platform at AMP 2025 . Multiple abstracts and a corporate workshop ...
Neuroblastoma RAS viral oncogene homolog (NRAS)-mutant melanoma is an aggressive form of skin cancer that develops because of ...
Revolution Medicines, Inc. (($RVMD)) announced an update on their ongoing clinical study. Revolution Medicines, Inc. is conducting a clinical ...
CR or mCR in 86% of patients within the first 12 months - Venetoclax-resistant secondary AML transformed from CMML responds to lenzilumab BURLINGAME, CA / ACCESS Newswire / November 4, 2025 / Taran ...
Machine learning–based identification of a metabolic gene prognostic signature (MALMPS) model to investigate the clinical and molecular heterogeneity of stage II/III colorectal cancer. Evaluating the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback